Chorionic Gonadotropin: Key Regulator of Fetal Development (G114335)

Target Name: CGB1

NCBI ID: G114335

CGB1

Chorionic Gonadotropin: Key Regulator of Fetal Development

Chorionic gonadotropin (CGF), also known as chorionic gonadotropin beta subunit (CGB), is a protein that plays a crucial role in the development and maintenance of human fetal gonads, including the placenta and the eggs. It is a key regulator of the pregnancy-related growth and development of the baby, and its levels have been shown to be abnormally low in women with various pregnancy complications, including preterm labor and low birth weight.

CGB is a member of the hormone family of the glycoproteins, which are a type of protein that consists of a glycan molecule and a protein tail. It is expressed in a variety of tissues throughout the body, including the brain, spinal cord, heart, and placenta.

CGB is involved in the development and maintenance of the neural tube, which will eventually become the baby's brain and spinal cord. During embryonic development, CGB plays a vital role in the formation and growth of the neural tube, and it is required for the development of the neural tube into the brain and spinal cord.

In addition to its role in neural tube development, CGB is also involved in the regulation of fetal growth and development. It has been shown to play a key role in the regulation of fetal blood flow, which is essential for the proper growth and development of the baby. CGB also regulates the production of certain hormones that are essential for fetal growth and development, including insulin, growth hormone, and progesterone.

CGB is also involved in the regulation of the immune system, which is essential for the proper functioning of the baby during pregnancy. It has been shown to play a key role in the development and regulation of the immune cells that are present in the placenta, which are responsible for protecting the baby from harmful substances that may be present in the amniotic fluid.

CGB is also involved in the regulation of the production of certain proteins that are essential for the development and growth of tissues in the body. It has been shown to play a key role in the production of the proteins called cadherins, which are essential for the development and growth of tissues such as the skin, heart, and lungs.

CGB is also involved in the regulation of the production of certain hormones that are essential for the growth and development of the baby. It has been shown to play a key role in the production of the hormones called sex hormones, which are essential for the development and growth of the baby's sex characteristics.

CGB is also involved in the regulation of the development and growth of the baby's bones and teeth. It has been shown to play a key role in the production of the proteins that are essential for the growth and development of the baby's bones and teeth, and it is required for the proper development of the baby's bones and teeth.

CGB is also involved in the regulation of the production of certain hormones that are essential for the growth and development of the baby's skin. It has been shown to play a key role in the production of the hormones called vitamin D, which is essential for the growth and development of the baby's skin.

CGB is also involved in the regulation of the production of certain hormones that are essential for the growth and development of the baby's hair and nails. It has been shown to play a key role in the production of the hormones called erythropoietin, which is essential for the growth and development of the baby's hair and nails.

CGB is also involved in the regulation of the production of certain hormones that are essential for the growth and development of the baby's muscles and bones. It has been shown to play

Protein Name: Chorionic Gonadotropin Subunit Beta 1

The "CGB1 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about CGB1 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets